在健康计划中嵌入实用临床试验的实用指南:大型简单的试验并不那么简单
Noelle M Cocoros1, Jerry H Gurwitz2, Mark J Cziraky3
1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Clinical trials (London, England)
|June 16, 2023
概括
医疗保险计划中嵌入的实用试验利用大型数据集进行高效的研究. 这些研究提供了独特的机会,通过产生有意义的临床变化的证据来改善护理和人口健康.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 临床试验方法论 临床试验方法论
- 医疗信息学 医疗信息学
背景情况:
- 医疗保险计划拥有大量关于人口统计,覆盖率和医疗保健利用率的纵向数据.
- 这些数据包括处方药,疫苗接种,行为健康接触以及一些实验室结果.
- 这些丰富的数据集可以有效地识别符合条件的患者,并确定实用性试验的结果.
研究的目的:
- 描述从医疗保险计划中规划和进行嵌入实用试验中吸取的经验教训.
- 突出这些试验的独特机会和考虑因素.
- 用健康计划数据为未来的研究提供信息.
主要方法:
- 利用国家卫生研究院实用试验协作分布式研究网络的经验.
- 分析参与美国食品和药物管理局哨兵系统的健康计划数据.
- 描述了使用网络的三项研究和一项单一健康计划研究.
主要成果:
- 该研究网络为拥有商业或Medicare Advantage健康计划的7500多万个人提供数据.
- 学到的经验教训来自该网络中正在进行和计划的研究.
- 这些发现强调了健康计划内嵌的研究的可行性和价值.
结论:
- 嵌入到健康计划中的实用试验产生了临床上显著的护理改进的关键证据.
- 这些试验的独特方面需要在规划,实施和分析过程中仔细考虑.
- 需要大样本规模和简单,可传播的干预措施的试验非常适合健康计划设置,最大限度地提高可用数据的影响.
相关概念视频
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:12Hazard Ratio
166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
166
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K